BioWorld MedTech

Jan. 28, 2010

Prostate cancer treatments vary at county vs. private hospitals

Researchers at Moores Cancer Center at the University of California, San Diego (UCSD) and colleagues have found that prostate cancer treatments varied significantly between county hospitals and private providers. (Medical Device Daily) Read More

Halt's fibroid device, procedure to make other treatments 'irrelevant'

International report: Varian Medical certified to assemble X-ray tubes in China

BrandWatch develops marker to spot counterfeit devices

Washington roundup: Prior FDA move on drug tests opposed by Congress and DEA

Today's MDD food for med-tech thought

Financings roundup: HeartWare seeks to raise $50M in public offering of 1.5M shares

Agreements/contracts: Opsens' sensor tech integrated with Abiomed's heart pump

Patent watch: Neurologix gains protection for Parkinson's disease tech

Deals roundup: Imagine Media signs non-binding letter of intent to acquire DMI

Grants roundup: GE gets $3.27M to bring medical imaging to undeveloped countries

Med-Tech Notes

Product Briefs

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for Nov. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for November 27, 2024.

Illustration of man holding magnifying glass to human body model showing muscle anatomy

In muscular dystrophies, gene therapies race the clock

BioWorld

Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...

AI-generated illustration of heart and metabolic impact

Bridgebio, with FDA approval, faces Pfizer in ATTR

BioWorld

With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...

‘Evo’ AI can design complete genomes

BioWorld Science

The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...